Patents by Inventor Kaijun GENG

Kaijun GENG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240383924
    Abstract: Disclosed are a series of benzopyrimidine compounds and a use thereof, and specifically disclosed are compounds represented by formula (II) and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: July 10, 2024
    Publication date: November 21, 2024
    Inventors: Yang ZHANG, Wentao WU, Kaijun GENG, Jikui SUN, Yangyang XU, Jian LI, Shuhui CHEN
  • Publication number: 20240239802
    Abstract: A crystal form of a compound of formula (I), a preparation method therefor, and an application of the crystal form in the preparation of a drug for treating related diseases.
    Type: Application
    Filed: May 10, 2022
    Publication date: July 18, 2024
    Applicant: ZHEJIANG LONGCHARM BIO-TECH PHARMA. CO., LTD.
    Inventors: Yang ZHANG, Wentao WU, Kaijun GENG
  • Publication number: 20240217973
    Abstract: Provided are a series of imidazopyridine compounds and a use thereof, and in particular, relating to compounds as represented by formula (P), and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: April 15, 2022
    Publication date: July 4, 2024
    Inventors: Yang ZHANG, Wentao WU, Kaijun GENG, Rongxin HUANG, Shuhui CHEN
  • Publication number: 20240174692
    Abstract: Provided are pyrimidine aromatic ring compounds. Specifically provided is a compound as represented by formula (II) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 9, 2022
    Publication date: May 30, 2024
    Applicant: Medshine Discovery Inc.
    Inventors: Yang Zhang, Wentao Wu, Kaijun Geng, Yangyang Xu, Zhixiang Li, Shuhui Chen
  • Publication number: 20240002377
    Abstract: A pyrrolopyridine compound and an application thereof. Specifically disclosed is a compound represented by formula (P) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 7, 2021
    Publication date: January 4, 2024
    Inventors: Yang Zhang, Wentao Wu, Kaijun Geng, Yangyang Xu, Shuhui Chen
  • Publication number: 20230357248
    Abstract: Disclosed are a pyrrolopyrimidine compound and a use thereof in preparing a medicine for diseases related to a BTK protein kinase inhibitor. Specially, disclosed are a compound as shown in formula (III) and a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 13, 2020
    Publication date: November 9, 2023
    Inventors: Yang ZHANG, Wentao WU, Kaijun GENG, Qiu LI, Jian LI, Shuhui CHEN